Related Experiment Video

Updated: Aug 17, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Secretase-dependent tyrosine phosphorylation of Mdm2 by the ErbB-4 intracellular domain fragment

Rajeswara Rao Arasada1, Graham Carpenter

  • 1Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, USA.

The Journal of Biological Chemistry
|June 30, 2005
PubMed

Insights

Heregulin binding to ErbB-4 receptor tyrosine kinase triggers Hdm2 phosphorylation. This process requires the ErbB-4 intracellular domain (ICD) fragment, which also enhances p53 activity.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Receptor tyrosine kinases (RTKs) play crucial roles in cell signaling and cancer.
  • ErbB-4 is an RTK involved in breast cancer development.
  • Hdm2 is a key regulator of the tumor suppressor p53.

Purpose of the Study:

  • To investigate the role of ErbB-4 signaling in Hdm2 regulation.
  • To determine the involvement of the ErbB-4 intracellular domain (ICD) fragment in this process.
  • To elucidate the impact of ErbB-4 ICD on p53 pathway activation.

Main Methods:

  • Utilized ZR-75-1 breast cancer cells and 32D cells.
  • Employed secretase inhibition (alpha- and gamma-secretase).
  • Expressed ErbB-4 ICD fragment in H1299 cells.
  • Performed ubiquitination assays and luciferase reporter assays.

Main Results:

  • Heregulin-induced ErbB-4 activation led to Hdm2 tyrosine phosphorylation, dependent on secretase activity.
  • ErbB-4 ICD fragment associated with Hdm2 and caused its phosphorylation.
  • ErbB-4 ICD expression promoted Hdm2 ubiquitination, increasing p53 and p21 levels.
  • ErbB-4 ICD enhanced p53 transcriptional activity on the p21 promoter.

Conclusions:

  • ErbB-4 signaling, via its ICD fragment, modulates Hdm2 activity.
  • The ErbB-4 ICD fragment promotes p53 pathway activation, suggesting a role in tumor suppression.
  • This study reveals a novel mechanism linking RTK signaling to p53 regulation.

More Related Videos

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment07:55

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment

Published on: September 25, 2017

Assaying Protein Kinase Activity with Radiolabeled ATP08:05

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...